NASIR RAMIN: Open Payments
NPI 1144388794 · CENTREVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 29 payments from 10 companies in 2025. Trend: 2023 $534 · 2024 $533 · 2025 $838
Food & beverage: $825Education: $14
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $274 |
| Amgen Inc. | 13 | $213 |
| GlaxoSmithKline, LLC. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ABBVIE INC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $34 |
| Lilly USA, LLC | 2 | $28 |
| Astellas Pharma US Inc | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
Products named: OTEZLA, BREZTRI, AIRSUPRA, PENMENVY, REXULTI, UBRELVY, MOUNJARO, Veozah.
Industry payments across VA — which companies pay providers there.
